FINWIRES · TerminalLIVE
FINWIRES

高盛第一季度业绩超出预期;首席执行官称伊朗战争旷日持久会带来通胀风险

By

-- 高盛(GS)公布的第一季度业绩超出市场预期,但首席执行官大卫·所罗门表示,旷日持久的中东冲突可能对通胀构成上行风险。 该银行公布的截至3月份的季度每股收益为17.55美元,高于去年同期的14.12美元,也高于FactSet调查的16.47美元的预期。净收入增长14%至172.3亿美元,超过华尔街预期的169.9亿美元。 周一,该行股价下跌3.6%。 根据FactSet的电话会议记录,首席执行官大卫·所罗门在财报电话会议上表示:“随着季度的推进,宏观环境开始对市场情绪造成压力,市场波动性显著增加,这主要是由于对人工智能驱动的颠覆性变革以及软件等行业的担忧,部分私人信贷领域的不确定性加剧,以及中东冲突的影响。” 自2月底美以与伊朗爆发战争以来,能源价格飙升。尽管美伊双方已同意暂时停火,但周末在巴基斯坦举行的谈判未能达成协议。 索罗门告诉分析师:“目前,伊朗经济基本面依然相对强劲。但如果冲突解决进程拖延,可能会对某些领域构成不利影响,尤其是通胀趋势。” 索罗门预测今年监管环境将更加有利,但他表示,地缘政治格局仍然“非常复杂”。 美国中央司令部周日表示,美军将于周一开始封锁进出伊朗港口的海上交通。 索罗门告诉分析师,由于中东冲突,首次公开募股(IPO)活动“略有放缓,尤其是在3月份”,但第一季度投资银行费用受益于并购交易量的增长。 高盛全球银行及市场业务收入同比增长19%,达到127.4亿美元。投资银行费用收入飙升48%,主要得益于咨询和股票承销收入的显著增长。固定收益、外汇及大宗商品收入下降10%。 资产及财富管理业务收入增长10%,达到40.8亿美元,主要得益于管理费和其他费用的增长,但部分被私人银行及贷款收入的下降所抵消。

Price: $874.94, Change: $-32.86, Percent Change: -3.62%

Related Articles

Asia

Dongjiang Environmental's Loss Widens 2.7% in Q1

Dongjiang Environmental (HKG:0895, SHE:002672) recorded an attributable loss of 150.2 million yuan in the first quarter of 2026, 2.7% wider than 146.3 million yuan a year prior, according to a Monday Hong Kong bourse filing.Loss per share widened to 0.14 yuan from 0.13 yuan in the corresponding period of the previous fiscal year.The waste disposal management company's revenue from operations declined 13% to 602.6 million yuan from 695.9 million yuan in the year-ago period.

$HKG:0895$SHE:002672
Sectors

Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday

Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.

$IBB$LGND$OGN$ORKA$XLV$XOMA
Asia

Zuoli Kechuang Logs Drop in Q1 Profit

Zuoli Kechuang Micro-finance Company (HKG:6866) recorded a decline in attributable profit in the first quarter of 2026 to 13.6 million yuan from 14.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.Net interest income for the three months slipped to 28.4 million yuan from 35.2 million yuan in the year-ago period.

$HKG:6866